Results 171 to 180 of about 9,343 (245)

Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia

, 2018
Rebecca Sullivan, Alice Abraham, Christine Simpson, Elizabeth Olear, Thomas O. Carpenter, Yanhong Deng, Chuqing Chen, Karl Insogna   +7 more
openalex   +2 more sources

PRO132 DISEASE BURDEN OF X-LINKED HYPOPHOSPHATEMIA [PDF]

Value in Health, 2019
M.I. Luis Yanes, M. Diaz Curiel, C. Vicente Calderón, P. Peris Bernal, S. Marín del Barrio, M. Ramón Krauel, J. Hernández Jaras, J.J. Broseta Monzó, L. Espinosa Román, S. Mendizábal, L. Pérez Sukia, V. Mártinez Jiménez, C. Palazón, P. Juan, M.Á. Calleja, G. Ariceta, P. Montesdeoca, A. Jiménez, I. Nieto   +18 more
openaire   +1 more source

Two-year structural skeletal outcomes of burosumab therapy in pediatric X-linked hypophosphatemia: A radiographic cohort study. [PDF]

J Child Orthop
Lim H, Lee W, Choi N, Lee YJ, Shin CH, Lee YA, Ko JM, Song MH.   +7 more
europepmc   +1 more source

Burosumab in Chinese adults with X-linked hypophosphatemia: a phase 4 study. [PDF]

JBMR Plus
Liu W, Zhang Z, Wang Y, Pei Y, Xue Y, Ji Y, Sugimoto M, Kuriki M, Xia W.   +8 more
europepmc   +1 more source

Microstructural heterogenity in human bone affected by X-linked hypophosphatemia

Birkedal, Henrik, Didziokas, Marius, Faaborg, Anne Marie Møller, Sadetskaia, Anastasiia, Østergaard, Maja   +4 more
openalex   +1 more source

Burosumab in X-linked hypophosphatemia: a profile of its use in the USA [PDF]

, 2018
Katherine A. Lyseng‐Williamson
openalex   +1 more source

Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan. [PDF]

J Endocrinol Invest
Baroncelli GI, Barale M, Brandi ML, Camozzi V, Carrara S, Nicoletti MC, Castellano E, Cetani F, Comberiati P, Iorgi ND, Eller-Vainicher C, Emma F, Fintini D, Giannini S, Gianotti L, Grandone A, Grassi G, Mora S, Palermo A, Pigliaru F, Pitea M, Procopio M, Rochira V, Ruggeri RM, Ruggiero B, Stagi S, Vezzoli G, Corbetta S.   +27 more
europepmc   +1 more source

Improvement in Physical Function Associated With Burosumab in a Patient With X-linked Hypophosphatemia: A Case Report. [PDF]

Cureus
Fukushima M, Hashida R, Matsuse H, Hiraoka K.   +3 more
europepmc   +1 more source

X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells. [PDF]

Calcif Tissue Int
Falsetti I, Palmini G, Donati S, Aurilia C, Zonefrati R, Di Filippo L, Giustina A, Giannini S, Arcidiacono GP, Iantomasi T, Lazzerini D, Joos-Vandewalle P, Lee C, Brandi ML.   +13 more
europepmc   +1 more source

X-linked hypophosphatemia and tumor-induced osteomalacia: a narrative review and expert opinion on the diagnostic and therapeutic challenges in the era of burosumab. [PDF]

Orphanet J Rare Dis
Brandi ML, Vainicher CE, Fintini D, Giusti A, Magnolato A, Minisola S, Giannini S.   +6 more
europepmc   +1 more source